COMMUNIQUÉS West-GlobeNewswire

NANOBIOTIX présente de premières données prometteuses dans l'essai de phase I/II avec NBTXR3 dans les cancers du foie à l'ASCO GI

22/01/2018 - 08:02

Nanobiotix présente de premières données prometteuses dans l'essai de phase I/II avec NBTXR3 dans les cancers du foie à l' American Society of Clinical Oncology Gastrointestinal Annual Meeting (ASCO GI) Très bon profil [...]

Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in January and February

22/01/2018 - 08:00

Press Release 22 January 2018 Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in January and February Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, [...]

Sanofi to Acquire Bioverativ for $11.6 Billion

22/01/2018 - 07:10

Sanofi to Acquire Bioverativ for $11.6 Billion Expands Sanofi's presence in specialty care and strengthens leadership in rare diseases Adds leader in the growing hemophilia market and provides platform for expansion in [...]

Sanofi va acquérir Bioverativ pour 11,6 milliards de dollars

22/01/2018 - 07:10

Sanofi va acquérir Bioverativ pour 11,6 milliards de dollars Extension de la présence de Sanofi dans la médecine de spécialités et renforcement du leadership de Sanofi dans les maladies rares Acquisition d'un leader [...]

Sanofi to Acquire Bioverativ for $11.6 Billion

22/01/2018 - 07:04

Sanofi to Acquire Bioverativ for $11.6 Billion Expands Sanofi's presence in specialty care and strengthens leadership in rare diseases Adds leader in the growing hemophilia market and provides platform for expansion in [...]

Sanofi va acquérir Bioverativ pour 11,6 milliards de dollars

22/01/2018 - 07:04

Sanofi va acquérir Bioverativ pour 11,6 milliards de dollars Extension de la présence de Sanofi dans la médecine de spécialités et renforcement du leadership de Sanofi dans les maladies rares Acquisition d'un leader [...]

ABLYNX ANNOUNCES WARRANTS EXERCISE AND CONVERSION OF BONDS

22/01/2018 - 07:02

REGULATED INFORMATION GHENT, Belgium, 22 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an [...]

Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period

22/01/2018 - 07:01

Transaction expands Novartis Oncology neuroendocrine tumor (NET) treatment portfolio and adds radiopharmaceutical technology platform Lutathera® (lutetium Lu 177 dotatate), with a US PDUFA date of January 26, creates [...]

Gala Pharmaceuticals Sees 2018 as Breakthrough Year for Company

21/01/2018 - 08:30

ANAHEIM, Calif., Jan. 21, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceuticals Inc. (GPI) (OTCBB: GLPH ) today announced that it is focusing on key 2018 goals to drive success and build long-term shareholder value. Gala [...]

CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution

20/01/2018 - 02:43

GE supports CBMG in its aim to speed up manufacturing timelines for its CAR T-cell therapy clinical trials and future commercialization First GE Healthcare FlexFactory™ for cell therapy installation in the world [...]

Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018

19/01/2018 - 23:31

Company announcement - No. 4/2018 Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018 Zealand receives FDA approval of its Investigational [...]

U.S. FDA Grants Priority Review for Daratumumab in Front Line Multiple Myeloma

19/01/2018 - 23:27

Company Announcement U.S. FDA grants Priority Review to daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous [...]

MEDIA ADVISORY -- Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference

19/01/2018 - 22:56

ADVISORY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- WHAT: Dr. Heinrich Roder, Biodesix’ CTO, will speak on “Applied Machine Learning for Immuno-Oncology Diagnostics” in the “AI and Data Science Showcase” track at the Precision [...]

Meridian Bioscience, Inc. Expects to Report First Quarter Fiscal Year 2018 Operating Results on Thursday, January 25, 2018

19/01/2018 - 22:23

CINCINNATI, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading diagnostic and life science component company, expects to release its first quarter fiscal 2018 operating results before [...]

TiGenix: Transparency Information

19/01/2018 - 22:01

PRESS RELEASE REGULATED INFORMATION Transparency Information Leuven (BELGIUM) - January 19, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 [...]

Tonix Pharmaceuticals Announces Publication Reporting Synthesis, Construction and Characterization of a Potential Smallpox-Preventing Vaccine Candidate TNX-801 (Live Horsepox Virus from Cell Culture)

19/01/2018 - 20:00

NEW YORK, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, [...]

CorVel Announces Quarterly Earnings Release Webcast

19/01/2018 - 19:31

IRVINE, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- In conjunction with CorVel Corporation’s (NASDAQ: CRVL ) quarterly earnings release, CorVel will stream a webcast over the Internet on Tuesday, January 30 th at 11:30 am [...]

Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee

19/01/2018 - 18:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee Paris, France - January 19, 2018 [...]

Sanofi nomme Dominique Carouge au poste de Vice-Président Exécutif, Business Transformation, et membre du Comité Exécutif

19/01/2018 - 18:01

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi nomme Dominique Carouge au poste de Vice-Président Exécutif, Business Transformation, et membre du Comité Exécutif Paris, France - Le 19 janvier [...]